Rekom Biotech is listed as one of the top ten leading vendors in the Insight Partners' Viral Antigens Market Forecast to 2027 report


The Insight Partners makes reports that provide in-depth analysis on the selected topic, making a review of the most important companies in the sector, and restraints and opportunities available in the market.

The Viral Antigens Market Forecast to 2027 report provides a study of Viral Antigens market using SWOT analysis (Strength, Weakness, Opportunities and Threat to the organization), and also provides an in-depth survey of the key players in the market. This survey is based on various objectives of an organization, such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization. Rekom Biotech appears as one of the ten top leading vendors of the Viral Antigens market.

This report also evaluates the COVID-19 impact and makes a global analysis:

  • By component:
    • Influenza Viral Antigens
    • Coronavirus Antigens
    • Zika Virus Antigens
    • Ebola Virus Antigens
    • Dengue Virus Antigens
    • Herpes Simplex Virus (HSV) Antigens
    • Rotavirus Viral Antigens
    • Hepatitis A-E Virus Antigens
    • Measles Virus Antigens
    • Mumps/Parotitis Virus Antigens
    • and Others
  • By technique:
    • ELISA
    • Immunoassay
    • Hemagglutination
    • Radioimmunoassay (RIA)
    • Immunoperoxidase Staining
    • Immunofluorescence
    • and Others
  • By end-user:
    • Hospitals
    • Clinics
    • Laboratories
    • Diagnostic Centers
    • Blood Banks
    • Research Institutes
  • And by geography

For more information, please visit